Reliability of Laboratory-Developed Tests Called Into Question
A recent HHS announcement spurred concern that FDA oversight of LDTs was eroding, threatening patient safety — but the reality is less dire.
Head and Neck Cancer
HEAD AND NECK CANCER ADVISOR
FEATURED CONTENT
-
-
The Twitter Effect on How Oncologists Conduct and Share Research
The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources. -
Gardasil 9 for the Prevention of Some Head and Neck Cancers: Measuring the Benefit
The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval. -
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes. -
Conflicts of Interest Continue to Plague Oncology Guidelines and Research
New research presented at ASCO 2020 sheds light on conflicts of interest among NCCN panelists and links industry dollars to measures of academic success among junior faculty.
HEAD AND NECK CANCER NEWS
Experts Establish Surgical Priority Ranking for Head and Neck Cancers
Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer
Weight and Swallowing-Related Quality of Life in Patients Treated for Oropharyngeal Cancer
Adding Radiotherapy to Chemotherapy Boosts Survival in Nasopharyngeal Carcinoma
A 6-Gene Expression Signature May Predict Benefit From Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Head and Neck Cancer
